Results 151 to 160 of about 355,187 (399)
126 TRANSCUTANOUS OXYGEN TENSION (PtcO2) IN NEONATES WITH CYANOTIC CONGENITAL HEART DEFECTS (CCHD) AND PULMONARY DISEASE (PD) [PDF]
C Kull+4 more
openalex +1 more source
Abstract Background Gene transcription is crucial for embryo and postnatal development and is regulated by the Mediator complex. Mediator is comprised of four submodules, including the kinase submodule (CKM). The CKM consists of MED13, MED12, CDK8, and CCNC.
Anna K. Leinheiser+5 more
wiley +1 more source
Hypertrophic cardiomyopathy (HCM) caused by autosomal-dominant mutations in genes coding for structural sarcomeric proteins, is the most common inherited heart disease.
Sarala Raj Murthi+30 more
doaj +1 more source
BackgroundCongenital heart defects are common and occur in approximately 0.9% of births. In France, the registries cover approximately 20% of the population but not the entirety of France; therefore, we aimed to update the incidence data for congenital ...
Gurvan Bourdon+7 more
doaj +1 more source
Abstract Aims Atrial fibrillation (AF) in heart failure with reduced ejection fraction (HFrEF) has prognostic implications. Using a machine learning algorithm (FIND‐AF), we aimed to explore clinical events and the cardiac magnetic resonance (CMR) characteristics of the pre‐AF phenotype in HFrEF.
Anna Helbitz+15 more
wiley +1 more source
Transcatheter management of cyanotic congenital heart defects: A review [PDF]
P. Syamasundar Rao
openalex +1 more source
Abstract Aims Dapagliflozin, a sodium‐glucose cotransporter 2 (SGLT2) inhibitor, has shown clinical benefits in adults with heart failure (HF), improving cardiac function, reducing HF‐related hospitalizations and enhancing survival rates. While extensively studied in adult HF, data on its efficacy and safety in paediatric HF patients remain limited. We
Lisa‐Maria Rosenthal+5 more
wiley +1 more source
Pediatric Heart Conditions: What Do Occupational Therapists Need to Know? [PDF]
Rogers, Stefanie
core +2 more sources
Abstract Aims Heart–lung transplantation (HLTx) remains a life‐saving intervention for patients with end‐stage cardiopulmonary failure. We retrospectively analysed long‐term HLTx outcomes at our centre to assess survival trends and evaluate the impact of evolving immunosuppressive, surgical and perioperative strategies.
L. Lily Rosenthal+10 more
wiley +1 more source